World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 82 16165 15209 1483 1417 310 23638

Michael Brada publications per year

The chart shows the history of publications by Michael Brada between 1985 and 2024, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Michael Brada published across 40 years, from 1985 to 2024, averaging 7.8 papers a year. Output peaked at 19 publications in 1993. 1 of the 310 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1985 to 2024. Vertical axis: number of publications, 0 to 19. Peak 19 publications in 1993. 1985: 2 publications 1986: 2 publications 1987: 4 publications 1988: 4 publications 1989: 7 publications 1990: 6 publications 1991: 10 publications 1992: 13 publications 1993: 19 publications 1994: 11 publications 1995: 14 publications 1996: 9 publications 1997: 15 publications 1998: 6 publications 1999: 15 publications 2000: 15 publications 2001: 13 publications 2002: 11 publications 2003: 14 publications 2004: 7 publications 2005: 7 publications 2006: 5 publications 2007: 9 publications 2008: 8 publications 2009: 9 publications 2010: 8 publications 2011: 12 publications 2012: 8 publications 2013: 12 publications 2014: 6 publications 2015: 5 publications 2016: 2 publications 2017: 5 publications 2018: 5 publications 2019: 4 publications 2020: 1 publication 2021: 4 publications 2022: 2 publications 2023: 0 publications 2024: 1 publication
1985 2024

310 publications in total across all disciplines

View publications per year as a table
Michael Brada: publications per year, 1985 to 2024
Year Publications
1985 2
1986 2
1987 4
1988 4
1989 7
1990 6
1991 10
1992 13
1993 19
1994 11
1995 14
1996 9
1997 15
1998 6
1999 15
2000 15
2001 13
2002 11
2003 14
2004 7
2005 7
2006 5
2007 9
2008 8
2009 9
2010 8
2011 12
2012 8
2013 12
2014 6
2015 5
2016 2
2017 5
2018 5
2019 4
2020 1
2021 4
2022 2
2023 0
2024 1
Total 310
Download as CSV

Michael Brada publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael Brada sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 301–320 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 310 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834 310
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Michael Brada D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Brada sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 82–83 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027 82
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Michael Brada is affiliated with the University of Liverpool in the United Kingdom. Their research primarily focuses on fields related to medicine, with an emphasis on radiology, nuclear medicine and imaging, pulmonary and respiratory medicine, radiation, oncology, and epidemiology.

The scientist's main research topics cover lung cancer diagnosis and treatment, advanced radiotherapy techniques, effects of radiation exposure, medical imaging techniques and applications, pancreatic and hepatic oncology research, radiomics and machine learning in medical imaging, as well as meningioma and schwannoma management.

Michael Brada has contributed to several academic publications. Recent papers include:

  • "ESTRO ACROP guideline for target volume delineation of skull base tumors," 2020, Radiotherapy and Oncology
  • "Improving Outcomes in NSCLC: Optimum Dose Fractionation in Radical Radiotherapy Matters," 2022, Journal of Thoracic Oncology
  • "Afatinib and radiotherapy, with or without temozolomide, in patients with newly diagnosed glioblastoma: results of a phase I trial," 2021, Journal of Neuro-Oncology
  • "Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer," 2021, Radiation Oncology
  • "Dyspnea in Patients Receiving Radical Radiotherapy for Non-Small Cell Lung Cancer: A Prospective Study," 2020, Frontiers in Oncology

The scientist frequently collaborates with others in their field. Notable co-authors include:

  • John D. Fenwick
  • Helen Forbes
  • S. Ashley
  • Louise Turtle
  • Neeraj Bhalla

Michael Brada's work has been published repeatedly in several venues. Frequent publication journals include:

  • Journal of Thoracic Oncology
  • Radiotherapy and Oncology
  • Radiation Oncology
  • Journal of Neuro-Oncology
  • Frontiers in Oncology

Best Publications

  • A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

    W K A Yung;R E Albright;J Olson;R Fredericks

  • Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

    W. K.Alfred Yung;Michael D. Prados;Ricardo Yaya-Tur;Steven S. Rosenfeld

  • High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    R. Stupp;M. Brada;M. J. van den Bent;J.-C. Tonn

  • Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.

    M. Brada;D. Ford;S. Ashley;J. M. Bliss

  • Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years.

    G. Minniti;D. Traish;S. Ashley;A. Gonsalves

  • The long‐term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas

    M. Brada;B. Rajan;D. Traish;S. Ashley

  • Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

    M. Brada;K. Hoang-Xuan;R. Rampling;P. Y. Dietrich

  • Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).

    Riccardo Soffietti;Ufuk Abacioglu;Brigitta Baumert;Stephanie E Combs

  • High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    R. Stupp;J.-C. Tonn;M. Brada;G. Pentheroudakis

  • Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial

    Sally Moore;Jessica Corner;Jo Haviland;Mary Wells

  • Craniopharyngioma — long-term results following limited surgery and radiotherapy

    B. Rajan;S. Ashley;C. Gorman;C.C. Jose

  • The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires

    D. Osoba;N. K. Aaronson;M. Muller;K. Sneeuw

  • ESTRO-ACROP guideline "target delineation of glioblastomas"

    Maximilian Niyazi;Michael Brada;Anthony J Chalmers;Stephanie E Combs

  • Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas

    M. Brada;L. Viviers;C. Abson;F. Hines

  • Relocatable frame for stereotactic external beam radiotherapy.

    S.S. Gill;D.G.T. Thomas;A.P. Warrington;M. Brada

  • Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma

    Michael Brada;Sally Stenning;Rhian Gabe;Lindsay C. Thompson

  • Health-Related Quality of Life in Patients Treated With Temozolomide Versus Procarbazine for Recurrent Glioblastoma Multiforme

    David Osoba;M. Brada;W. K.A. Yung;M. Prados

  • Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies.

    M Brada;I Judson;P Beale;S Moore

  • Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.

    M. Bower;E. S. Newlands;N. M. Bleehen;M. Brada

  • Pathology and Genetics of Tumours of the Nervous System

    Michael Brada

Frequent Co-Authors

Stanley W. Ashley
Stanley W. Ashley Brigham and Women's Hospital
Alan Horwich
Alan Horwich Royal Marsden NHS Foundation Trust
Vincent Khoo
Vincent Khoo Royal Marsden NHS Foundation Trust
David Osoba
David Osoba University of British Columbia
Dirk De Ruysscher
Dirk De Ruysscher Maastricht University
Michael D. Prados
Michael D. Prados University of California, San Francisco
Michael Weller
Michael Weller University of Zurich
Ian Judson
Ian Judson Institute of Cancer Research
Douglas F. Easton
Douglas F. Easton University of Cambridge
Zoltan Szallasi
Zoltan Szallasi Boston Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a career in healthcare alongside or beyond traditional medical studies, there are several accessible online degree options worth considering. For example, those seeking a nursing path might explore the easiest nursing schools to get into, which offer flexible entry requirements and may help you start your career faster.

Not everyone aiming to work in healthcare needs direct patient contact. Those interested in administrative or behind-the-scenes roles might consider medical billing and coding schools online with financial aid. These programs can open doors to in-demand positions that support medical facilities nationwide.

If testing requirements like the TEAS or HESI exams are a concern, it’s possible to find do i need to take the teas test for lpn – resources that explain which programs offer more flexible admissions criteria.

For those interested in management or leadership, pursuing a health care administration degree online can prepare you to oversee clinics, hospitals, or health systems. These degree pathways can expand your impact within the growing healthcare industry, all while studying from the comfort of your home.

Best Scientists Citing Michael Brada

Trending Scientists

Recently Published Articles